Skip to main content

Advertisement

SpringerLink
Log in

Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

The Rho sub-family of proteins is involved in regulating the organization of the cytoskeleton and in cell motility. Our aim is to clarify the clinical significance of Rho protein in hepatocellular carcinomas (HCC) and to determine the relationship between the level of expression and patient outcome following hepatectomy. The expression of RhoA protein in HCC and corresponding non-tumor tissues of 26 patients who underwent surgical resection was analyzed by immunoblotting. The expression level of each case was calculated as tumor/non-tumor (T/N) ratios. High expression (T/N≥1) of RhoA protein in HCC compared to the paired non-tumor tissues was recognized in 18 patients (69.2%) of 26 samples. The activity of RhoA is also increased in HCC with high expression of RhoA. The high expression of RhoA protein did not correlate with various clinical parameters. However, the disease-free survival rates of the RhoA-high expression group (T/N≥1) were significantly lower than those of the RhoA-low expression group (T/N<1) (P<0.05). The high expression of RhoA protein in HCC plays an important role in intrahepatic recurrence of patients who underwent a hepatectomy for HCC, and RhoA is a useful marker for predicting early recurrence in an early-stage HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Adamson P, Marshall CJ, Hall A, Tilbrook PA (1992) Post-translational modifications of p21rho proteins. J Biol Chem 267:20033–20038

    PubMed  CAS  Google Scholar 

  • Avraham H, Weinberg RA (1989) Characterization and expression of the human rhoH12 gene product. Mol Cell Biol 9:2058–2066

    PubMed  CAS  Google Scholar 

  • Bourne HR, Sanders DA, McCormick F (1990) The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348:125–132

    Article  PubMed  CAS  Google Scholar 

  • Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, Ng IO (2003) Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J Biol Chem 278:10824–10830

    Article  PubMed  CAS  Google Scholar 

  • Fritz G, Just I, Kaina B (1999) Rho GTPases are over-expressed in human tumors. Int J Cancer 81:682–687

    Article  PubMed  CAS  Google Scholar 

  • Genda T, Sakamoto M, Ichida T, Asakura H, Kojiro M, Narumiya S, Hirohashi S (1999) Cell motility mediated by Rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology 30:1027–1036

    Article  PubMed  CAS  Google Scholar 

  • Hao J, Ju H, Zhao S, Junaid A, Scammell-LaFleur TK, Dixon IMC (1999) Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31:667–678

    Article  PubMed  CAS  Google Scholar 

  • Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H, Watanabe G, Tsurumaru M (1993) Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 71:19–25

    Article  PubMed  CAS  Google Scholar 

  • Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S (1999) An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 5:221–225

    Article  PubMed  CAS  Google Scholar 

  • Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, Oshima H (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9:2632–2641

    PubMed  CAS  Google Scholar 

  • Kawata S, Yamasaki E, Nagase T, Inui Y, Matsuda Y, Inada M, Tamura S, Noda S, Imai Y, Matsuzawa Y (2001) Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial. Br J Cancer 84:886–891

    Article  PubMed  CAS  Google Scholar 

  • Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Sone Y, Toyoda H, Shimada S, Takahashi M, Sassa T (1997) Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 25:87–92

    Article  PubMed  CAS  Google Scholar 

  • Lang P, Guizani L, Vitte-Mony I, Stancou R, Dorseuil O, Gacon G, Bertoglio J (1992) ADP-ribosylation of the ras-related, GTP-binding protein RhoA inhibits lymphocyte-mediated cytotoxicity. J Biol Chem 267:11677–11680

    PubMed  CAS  Google Scholar 

  • Leung TH, Ching YP, Yam JW, Wong CM, Yau TO, Jin DY, Ng IO (2005) Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. Proc Natl Acad Sci USA 102:15207–15212

    Article  PubMed  CAS  Google Scholar 

  • Machesky LM, Hall A (1996) Rho: a connection between membrane receptor signaling and the cytoskeleton. Trends Cell Biol 6:304–310

    Article  PubMed  CAS  Google Scholar 

  • Makuuchi M, Kosuge T, Takayasu T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304

    Article  PubMed  CAS  Google Scholar 

  • Nakashima T (1976) Vascular changes and hemodynamics in hepatocellular carcinoma. In: Okuda K, Peter RL (eds) Hepatocellular carcinoma. Wiley, New York, pp 169–203

    Google Scholar 

  • Narumiya S, Morii N (1993) Rho gene products, botulinum C3 exoenzyme and cell adhesion. Cell Signal 5:9–19

    Article  PubMed  CAS  Google Scholar 

  • Perona R, Esteve P, Jimenez B, Ballestero RP, Ramon y Cajal S, Lacal JC (1993) Tumorigenic activity of rho genes from Aplysia californica. Oncogene 8:1285–1292

    PubMed  CAS  Google Scholar 

  • Ren X, Kiosses WB, Schwartz MA (1999) Regulation of the small GTP-binding protein Rho by cell adhesion and cytoskeleton. EMBO J 18:578–585

    Article  PubMed  CAS  Google Scholar 

  • Sebti SM, Hamilton AD (1997) Inhibition of Ras prenylation: a novel approach to cancer chemotherapy. Pharmacol Ther 74:103–114

    Article  PubMed  CAS  Google Scholar 

  • Simonetti RG, Camma C, Fiorello F, Politi F, D’Amico G, Pagliaro L (1991) Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 36:962–972

    Article  PubMed  CAS  Google Scholar 

  • Takaishi K, Sasaki T, Kotani H, Nishioka H, Takai Y (1997) Regulation of cell–cell adhesion by rac and rho small G proteins in MDCK cells. J Cell Biol 139:1047–1059

    Article  PubMed  CAS  Google Scholar 

  • Takamura M, Sakamoto M, Genda T, Ichida T, Asakura H, Hirohashi S (2001) Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632. Hepatology 33:577–581

    Article  PubMed  CAS  Google Scholar 

  • Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990–999

    Article  PubMed  CAS  Google Scholar 

  • Yoshioka K, Matumura F, Akedo H, Itoh K (1998) Small GTP-binding protein rho stimulates the actomyosin system, leading to invasion of tumor cells. J Biol Chem 276:5146–5154

    Article  Google Scholar 

  • Yoshioka K, Nakamoto S, Itoh K (1999) Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res 59:2004–2010

    PubMed  CAS  Google Scholar 

  • Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241–269

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology and Hepatology, Graduate School of Medicine, Osaka University, 2-2, K1, Yamada-oka, Suita, Osaka, 565-0871, Japan

    Koji Fukui, Shinji Tamura, Akira Wada, Yoshihiro Kamada, Yoshiyuki Sawai, Kazuho Imanaka, Takahiko Kudara & Norio Hayashi

  2. Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, 2-2, B5, Yamada-oka, Suita, Osaka, 565-0871, Japan

    Iichiro Shimomura

Authors
  1. Koji Fukui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shinji Tamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akira Wada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshihiro Kamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoshiyuki Sawai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kazuho Imanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takahiko Kudara
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Iichiro Shimomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Norio Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Koji Fukui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukui, K., Tamura, S., Wada, A. et al. Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma. J Cancer Res Clin Oncol 132, 627–633 (2006). https://doi.org/10.1007/s00432-006-0107-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-006-0107-7

Keywords

Search

Navigation